Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean M Post

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Biochimica Et Biophysica Acta. Molecular Cell Research|April 16, 2018
Role of MSC-derived galectin 3 in the AML microenvironmentPeter P Ruvolo, Vivian R Ruvolo, Jared K Burks, et al.
Cancer Cell|September 29, 2015
hnRNP K Is a Haploinsufficient Tumor Suppressor that Regulates Proliferation and Differentiation Programs in Hematologic MalignanciesMiguel Gallardo, Hun Ju Lee, Xiaorui Zhang, et al.
Oncotarget|November 2, 2017
Cancer testis antigen Sperm Protein 17 as a new target for triple negative breast cancer immunotherapyLeonardo Mirandola, Elisa Pedretti, Jose A Figueroa, et al.
NAR Cancer|December 15, 2022
Heterogeneous nuclear ribonucleoprotein K is overexpressed in acute myeloid leukemia and causes myeloproliferation in mice via altered <i>Runx1</i> splicingMarisa J L Aitken, Prerna Malaney, Xiaorui Zhang, et al.
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|November 26, 2023
Insight into the mechanism of AML del(9q) progression: hnRNP K targets the myeloid master regulators CEBPA (C/EBPα) and SPI1 (PU.1)Kerstin Rahn, Ali T Abdallah, Lin Gan, et al.
Haematologica|November 4, 2021
AXL/MERTK inhibitor ONO-7475 potently synergizes with venetoclax and overcomes venetoclax resistance to kill <i>FLT3</i>-ITD acute myeloid leukemiaSean M Post, Huaxian Ma, Prerna Malaney, et al.
The Journal of Experimental Medicine|August 3, 2016
Role of neoplastic monocyte-derived fibrocytes in primary myelofibrosisSrdan Verstovsek, Taghi Manshouri, Darrell Pilling, et al.
Journal of the National Cancer Institute|May 12, 2019
Uncovering the Role of RNA-Binding Protein hnRNP K in B-Cell LymphomasMiguel Gallardo, Prerna Malaney, Marisa J L Aitken, et al.
Blood Advances|May 9, 2022
High-sensitivity next-generation sequencing MRD assessment in ALL identifies patients at very low risk of relapseNicholas J Short, Hagop Kantarjian, Farhad Ravandi, et al.
Nature Communications|November 15, 2014
CSN6 drives carcinogenesis by positively regulating Myc stabilityJian Chen, Ji-Hyun Shin, Ruiying Zhao, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Biochimica Et Biophysica Acta. Molecular Cell Research|April 16, 2018
Role of MSC-derived galectin 3 in the AML microenvironmentPeter P Ruvolo, Vivian R Ruvolo, Jared K Burks, et al.
Cancer Cell|September 29, 2015
hnRNP K Is a Haploinsufficient Tumor Suppressor that Regulates Proliferation and Differentiation Programs in Hematologic MalignanciesMiguel Gallardo, Hun Ju Lee, Xiaorui Zhang, et al.
Oncotarget|November 2, 2017
Cancer testis antigen Sperm Protein 17 as a new target for triple negative breast cancer immunotherapyLeonardo Mirandola, Elisa Pedretti, Jose A Figueroa, et al.
NAR Cancer|December 15, 2022
Heterogeneous nuclear ribonucleoprotein K is overexpressed in acute myeloid leukemia and causes myeloproliferation in mice via altered <i>Runx1</i> splicingMarisa J L Aitken, Prerna Malaney, Xiaorui Zhang, et al.
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|November 26, 2023
Insight into the mechanism of AML del(9q) progression: hnRNP K targets the myeloid master regulators CEBPA (C/EBPα) and SPI1 (PU.1)Kerstin Rahn, Ali T Abdallah, Lin Gan, et al.
Haematologica|November 4, 2021
AXL/MERTK inhibitor ONO-7475 potently synergizes with venetoclax and overcomes venetoclax resistance to kill <i>FLT3</i>-ITD acute myeloid leukemiaSean M Post, Huaxian Ma, Prerna Malaney, et al.
The Journal of Experimental Medicine|August 3, 2016
Role of neoplastic monocyte-derived fibrocytes in primary myelofibrosisSrdan Verstovsek, Taghi Manshouri, Darrell Pilling, et al.
Journal of the National Cancer Institute|May 12, 2019
Uncovering the Role of RNA-Binding Protein hnRNP K in B-Cell LymphomasMiguel Gallardo, Prerna Malaney, Marisa J L Aitken, et al.
Blood Advances|May 9, 2022
High-sensitivity next-generation sequencing MRD assessment in ALL identifies patients at very low risk of relapseNicholas J Short, Hagop Kantarjian, Farhad Ravandi, et al.
Nature Communications|November 15, 2014
CSN6 drives carcinogenesis by positively regulating Myc stabilityJian Chen, Ji-Hyun Shin, Ruiying Zhao, et al.
Pageof 5